Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells

Blood

Volumn 98, Issue 2, 2001, Pages 313-321

  Matsushima, Takamitsu ^a,b,c   Nakashima, Manabu ^a,b,c   Oshima, Koichi ^a,b,c   Abe, Yasunobu ^a,b,c   Nishimura, Junji ^a,b,c   Nawata, Hajime ^a,b,c   Watanabe, Takeshi ^a,b,c   Muta, Koichiro ^a,b,c  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; FAS ANTIBODY; GLYCOPHORIN A; RECEPTOR BINDING CANCER ANTIGEN; TRANSFERRIN RECEPTOR; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL MATURATION; CONTROLLED STUDY; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; HISTOCHEMISTRY; HUMAN; HUMAN CELL; MACROPHAGE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; ANTIGENS, CD95; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; APOPTOSIS; BONE MARROW CELLS; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; CELL DIVISION; COLONY-FORMING UNITS ASSAY; CYTOPLASM; ENZYME ACTIVATION; ERYTHROID PROGENITOR CELLS; ERYTHROPOIETIN, RECOMBINANT; FEMALE; GLYCOPHORIN; GRANULOCYTES; HISTOCYTOCHEMISTRY; HUMANS; MACROPHAGES; MEMBRANE POTENTIALS; RECEPTORS, CELL SURFACE; RECEPTORS, TRANSFERRIN; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS;

EID: 0035880241     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.2.313     Document Type: Article

References (42)

1. Muta K, Krantz SB, Bondurant MC, Wickrema A. Distinct role of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells. J Clin Invest. 1994;94:34-43.
2. Muta K, Krantz SB. Apoptosis of human erythroid colony-forming cells is decreased by stem cell factor and insulin-like growth factor I as well as erythropoietin. J Cell Physiol. 1993;156:264-271.
3. Muta K, Krantz SB, Bondurant MC, Dai CH. Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation. Blood, 1995;86:572-580.
4. Nagata S, Golstein P. The Fas death factor. Science. 1995;267:1449-1456.
5. Koury MJ, Bondurant MC. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells, Science. 1990;248:378-381.
6. Stahnke K, Hecker S, Kohne E, Debatin KM. CD95 (APO-1/FAS)-mediated apoptosis in cytokine-activated hematopoietic cells. Exp Hematol. 1998;26:844-850.
7. + human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood. 1995;85:3183-3190.
8. Schneider E, Moreau G, Arnould A, et al. Increased fetal and extramedullary hematopoiesis in Fas-deficient C57BL/6-Ipr/Ipr mice. Blood. 1999;94:2613-2621.
9. Fecho K, Bentley SA, Cohen PL. Mice deficient in Fas ligand (gld) or Fas (Ipr) show few alterations in granulopoiesis. Cell Immunol. 1998;188:19-32.
10. Adachi M, Suematsu S, Suda T, et al. Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc Natl Acad Sci U S A. 1996;93:2131-2136.
11. Nakashima M, Sonoda K, Watanabe T. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med. 1999;5:938-942.
12. Sonoda K, Nakashima M, Saito T, et al. Establishment of a new human uterine cervical adenocarcinoma cell line, SiSo, and its reactivity to anticancer agents. Int J Oncol. 1995;6:1099-1104.
13. Sonoda K, Nakashima M, Kaku T, Kamura T, Nakano H, Watanabe T. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer, 1996;77:1501-1509.
14. Sawada K, Krantz SB, Kans JS, et al. Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin. J Clin Invest. 1987;80:357-366.
15. Sawada K, Krantz SB, Dessypris EN, Koury ST, Sawyer ST. Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development. J Clin Invest. 1989;83:1701-1709.
16. Choi I, Muta K, Wickrema A, Krantz SB, Nishimura J, Nawata H. Interferon gamma delays apoptosis of mature erythroid progenitor cells in the absence of erythropoietin. Blood. 2000;95:3742-3749.
17. Zamzami N, Marchetti P, Castedo M, et al. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med. 1995;182:367-377.
18. Marchetti P, Castedo M, Susin SA, et al. Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med. 1996;184:1155-1160.
19. + T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists. Blood. 1996;87:4959-4966.
20. Miwa K, Hashimoto H, Yatomi T, Nakamura N, Nagata S, Suda T. Therapeutic effect of an antiFas ligand mAb on lethal graft-versus-host disease. Int Immunol. 1999;11:925-931.
21. Greenberg PL. Apoptosis and its role in the myelodysplastic syndromes: implications for disease natural history and treatment. Leuk Res. 1998;22:1123-1136.
22. Parker JE, Mufti GJ. Ineffective haemopoiesis and apoptosis in myelodysplastic syndromes. Br J Haematol. 1998;101:220-230.
23. Clarkson BD, Strife A, Wisniewski D, Lambek C, Carpino N. New understanding of the pathogenesis of CML: a prototype of early neoplasia. Leukemia. 1997;11:1404-1428.
24. Wickremasinghe RG, Hoffbrand AV. Biochemical and genetic control of apoptosis: relevance to normal hematopoiesis and hematological malignancies. Blood. 1999;93:3587-3600.
25. Dai CH, Price JO, Brunner T, Krantz SB. Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon γ to produce erythroid cell apoptosis. Blood. 1998;91:1235-1242.
26. Dai CH, Krantz SB. Interferon γ induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid cells. Blood. 1999;93:3309-3316.
27. Veiby OP, Jacobsen FW, Cui L, Lyman SD, Jacobsen SEW. The f/t3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential: suppression of apoptosis and counteraction by TNF-α and TGF-β. J Immunol. 1996;157:2953-2960.
28. Takenaka K, Nagafuji K, Harada M, et al. In vitro expansion of hematopoietic progenitor cells induces functional expression of Fas antigen (CD95). Blood. 1996;88:2871-2877.
29. Nagafuji K, Shibuya T, Harada M, et al. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. 1995;86:883-889.
30. Maria RD, Testa U, Luchetti L, et al. Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis. Blood. 1999;93:796-803.
31. Zamai L, Secchiero P, Pierpaoli S, et al. TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis. Blood. 2000;95:3716-3724.
32. Mariani SM, Matiba B, Armandola EA, Krammer PH. Interleukin 1β-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells. J Cell Biol. 1997;137:221-229.
33. Walczak H, Degli-Esposti MA, Johnson RS, et al. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J. 1997;16:5386-5397.
34. Sonoda K, Kaku T, Kamura T, Nakashima M, Watanabe T, Nakano H. Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias. Clin Cancer Res. 1998;4:1517-1520.
35. Kaku T, Sonoda K, Kamura T, et al. The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix. Clin Cancer Res. 1999;5:1449-1453.
36. Scaffidi C, Fulda S, Srinivasan A, et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 1998;17:1675-1687.
37. Susin SA, Zamzami N, Kroemer G. Mitochondria as regulators of apoptosis: doubt no more. Biochim Biophys Acta. 1998;1366:151-165.
38. Hirata H, Takahashi A, Kobayashi S, et al. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J Exp Med. 1996;167:567-600.
39. Hanspal M, Hanspal JS. The association of erythroblasts with macrophages promotes erythroid proliferation and maturation: a 30-kD heparinbinding protein is involved in this contact. Blood. 1994;84:3494-3504.
40. Roodman GD, Bird A, Hutzler D, Montgomery W. Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells. Exp Hematol. 1987;15:928-935.
41. Wang CQ, Udupa KB, Xiao H, Lipschitz DA. Evidence suggesting a negative regulatory role for macrophages in murine erythropoiesis in vivo. Exp Hematol. 1994;22:370-376.
42. Mohandas N. Cell-cell interactions and erythropoiesis. Blood Cells. 1991;17:59-64.